Bain Capital invests in Viewpoint Construction Software

Bain Capital has made an undisclosed investment in Viewpoint Construction Software. As part of the transaction, Updata Partners and TA Associates are selling their stakes in Viewpoint. Credit Suisse and Canaccord Genuity advised Viewpoint on the deal while Wells Fargo advised Bain Capital. Headquartered in Portland, Oregon, Viewpoint is a provider of software solutions and services to the construction sector.

Seidler-backed Sportman’s Warehouse rolls out IPO

Sportsman’s Warehouse Holdings, a portfolio company of Seidler Equity Partners, has launched its IPO of 12.5 million shares after pricing it at $9.50 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “SPWH.” Credit Suisse and Goldman Sachs are the lead underwriters. Based in Midvale, Utah, Sportman’s is an outdoor sporting goods retailer.

113 Views

Behrman Capital completes $570 mln recap of Pelican Products

New York and San Francisco-based private equity firm Behrman Capital said Tuesday that it has recapitalized Pelican Products for $570 million. Credit Suisse and Morgan Stanley were co-bookrunners on the transaction. Pelican Products is a producer of high-performance case solutions and advanced portable lighting systems.

Chinese online retailer Jumei seeks to raise $400 mln for IPO

According to an SEC filing, Jumei International Holding Limited has filed for a $400 million IPO. The number of shares that will be sold as well as the stock’s pricing terms have yet to be determined. Goldman Sachs (Asia), Credit Suisse and J.P. Morgan will serve as lead underwriters. Based in Beijing, Jumei, which is backed by Sequoia Capital and Ventech, is an online retailer.

Sheridan Healthcare hires banks for IPO – WSJ

Sheridan Healthcare Inc, a physician services company, has hired banks for an initial public offering, which may raise between $400 million and $500 million, the Wall Street Journal reported, citing people familiar with the matter.

155 Views

Belgian 3D printing firm Materialise files for IPO

Materialise NV, which is backed by Sniper Investments, has filed for an IPO. The number of shares that will be offered as well as the stock’s pricing terms have yet to be set. Materialise does plan on trading the stock on the NASDAQ. Piper Jaffray and Credit Suisse will serve as lead underwriters. Based in Belgium, Materialise is a 3D printing company.

161 Views

Lone Star Funds agrees to buy DFC Global Corp for about $1.3 bln

DFC Global Corp said Wednesday that it has agreed to be acquired by Lone Star Funds for approximately $1.3 billion. According to terms of the agreement, DFC Global shareholders will receive $9.50 in cash for each share of DFC common stock they own. The deal is expected to be completed in the third quarter of 2014. Houlihan Lokey Capital advised DFC Global on the transaction while Jefferies was the lead financial advisor to Lone Star Funds. Jefferies Finance and Credit Suisse are providing debt financing for the acquisition. DFC Global Corp. is a provider of alternative financial services.

170 Views

DLJ Merchant Banking Partners spins out from Credit Suisse

DLJ Merchant Banking Partners, Credit Suisse‘s mid-market leveraged buyout business, has spun off into an independent advisory firm, aPriori Capital Partners, established by the existing DLJ MBP management team led by Colin Taylor and Susan Schnabel. aPriori Capital will manage the DLJ Merchant Banking Partners III, L.P. and DLJ Merchant Banking Partners IV, L.P. private equity funds (together with related vehicles, the MBP Funds), collectively representing approximately $2 billion of value across 22 portfolio companies as of December 31, 2013.

VC-backed Akebia Therapeutics launches IPO

Akebia Therapeutics has launched its IPO of over 5.8 million shares at $17 per share. The stock began trading Thursday on the NASDAQ under the ticker symbol “AKBA.” Morgan Stanley, Credit Suisse and UBS Investment Bank are the lead underwriters. Based in Cincinnati, OH, Akebia Therapeutics is a biotech company focused on developing treatments for anemia and cancer. Its backers include Satter Investment Management, Novo A/S, Novartis Venture Funds, Kearny Venture Partners, Athenian Venture Partners and Triathlon Medical Ventures.

PEHUB Community

Join the 12494 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Psst! Got any hot tips?

  • This field is for validation purposes and should be left unchanged.

Look Who’s Tweeting

Reuters VC and PE feed

RSS Feed Widget

Groups